Drug culture

Cosmic Releases Extract Line Dedicated to Last Prisoner Project

Retrieved on: 
Tuesday, July 13, 2021
Entheogens, Cannabis, Steve DeAngelo, Yippies, LPP, Psychoactive drugs, Drug culture

SANTA ROSA, Calif., July 13, 2021 /PRNewswire/ -- Cosmic today announced a new line of concentrates branded to increase awareness for the Last Prisoner Project (LPP), a non-profit organization dedicated to cannabis criminal justice reform.

Key Points: 
  • SANTA ROSA, Calif., July 13, 2021 /PRNewswire/ -- Cosmic today announced a new line of concentrates branded to increase awareness for the Last Prisoner Project (LPP), a non-profit organization dedicated to cannabis criminal justice reform.
  • Cosmic, an award-winning California extracts brand, developed a new line of packaging for the collaboration with LPP.
  • "Last Prisoner project is incredibly grateful for the support of Cosmic.
  • The Last Prisoner Project (LPP) is a nonprofit organization dedicated to cannabis-related criminal justice reform.

Verano CEO to Participate in Cantor Fitzgerald Investor Fireside Chat

Retrieved on: 
Tuesday, July 13, 2021
Health sciences, Medicine, Health care, Cannabis culture, Cannabis shop, Drug culture, Cannabis industry, Medical cannabis

CHICAGO, July 13, 2021 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (Verano or the Company), a leading multi-state cannabis company, today announced that its Founder and Chief Executive Officer, George Archos, will participate in Cantor Fitzgeralds cannabis focused Weednesday Series, an investor fireside chat on Wednesday, July 14 at 11:00 AM ET.

Key Points: 
  • CHICAGO, July 13, 2021 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (Verano or the Company), a leading multi-state cannabis company, today announced that its Founder and Chief Executive Officer, George Archos, will participate in Cantor Fitzgeralds cannabis focused Weednesday Series, an investor fireside chat on Wednesday, July 14 at 11:00 AM ET.
  • The event will be hosted by Pablo Zuanic, Managing Director, U.S. Consumer and Cannabis Equity Analyst at Cantor Fitzgerald.
  • With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands: Verano, Avexia, Encore, and MV.
  • Verano designs, builds, and operates dispensaries under retail brands Zen Leaf and MV, delivering a superior cannabis shopping experience in both medical and adult-use markets.

Psychedelic Decriminalization Creating Market Opportunities

Retrieved on: 
Monday, July 12, 2021
Hallucinations, Master of Medicine, Psychedelic drug, Health sciences, Medication, Health, Draft:MindMed, Drug culture

Legalization efforts began with marijuana in 2018, creating a booming market for investors.

Key Points: 
  • Legalization efforts began with marijuana in 2018, creating a booming market for investors.
  • Now, the psychedelics market is in the spotlight, with states across America looking to decriminalize psychedelic mushrooms.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED)is a clinical-stage psychedelic medicine biotech company that develops psychedelic medicines and therapies for the treatment of mental illness and addiction.
  • COMP360, if approved, could receive up to 11 years of market exclusivity in the EU and US.

Psychedelic Decriminalization Creating Market Opportunities

Retrieved on: 
Monday, July 12, 2021
Hallucinations, Master of Medicine, Psychedelic drug, Health sciences, Medication, Health, Draft:MindMed, Drug culture

Legalization efforts began with marijuana in 2018, creating a booming market for investors.

Key Points: 
  • Legalization efforts began with marijuana in 2018, creating a booming market for investors.
  • Now, the psychedelics market is in the spotlight, with states across America looking to decriminalize psychedelic mushrooms.
  • Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (NEO: MMED)is a clinical-stage psychedelic medicine biotech company that develops psychedelic medicines and therapies for the treatment of mental illness and addiction.
  • COMP360, if approved, could receive up to 11 years of market exclusivity in the EU and US.

Auxly on a Hot Streak Heading into a Summer Packed with New Products

Retrieved on: 
Monday, July 12, 2021
Entheogens, Euphoriants, Medicinal plants, Psychoactive drugs, Plants, Cannabis, Cannabis smoking, Brand, Drug culture

Further, the Company has moved up to the #6 position among Canadian Licensed Producers for the month of Juneiv.

Key Points: 
  • Further, the Company has moved up to the #6 position among Canadian Licensed Producers for the month of Juneiv.
  • Heres a look at the new products Canadian cannabis consumers can look forward to this summer from Auxlys in-house brands Kolab Project , Back Forty , Foray and Dosecann .
  • In addition to the above national product launches, Auxly is making the following unique edible products available to select provinces.
  • In addition, this release may contain forward-looking information attributed to third party sources, the accuracy of which has not been verified by Auxly.

Government of Canada announces the grand prize winner of the Drug Checking Technology Challenge

Retrieved on: 
Friday, July 9, 2021
Drug culture, Patty Hajdu, Government of Canada, Health Canada, Drug checking, Government, Health

Today, the Honourable Patty Hajdu, Minister of Health announced Scatr Inc. as the winner of Health Canada and Impact Canada's Drug Checking Technology Challenge.

Key Points: 
  • Today, the Honourable Patty Hajdu, Minister of Health announced Scatr Inc. as the winner of Health Canada and Impact Canada's Drug Checking Technology Challenge.
  • Scatr is receiving the $1 million grand prize for its innovative drug checking technology that quickly and accurately identifies the contents of potentially toxic illegal drugs and helps prevent overdoses.
  • Current options for drug checking technology are often expensive, complicated to use, or lacking accuracy and reliability.
  • To address this gap and accelerate innovation, the Government of Canada launched the Drug Checking Technology Challenge in 2018.

Ensysce Biosciences Receives Notice of Award for Year Three of Multi-Year NIDA Grant for the Clinical Development of its Next Generation Opioid Products with Overdose Protection

Retrieved on: 
Thursday, July 8, 2021
Psychoactive drugs, Morphinans, Euphoriants, Drug culture, Morphine, Oxycodone, Drug overdose, Opioid, Multifunction Phased Array Radar, Heroin

This award will provide $2.8 million to initiate a Phase 1 study of the first MPARoverdose protection product in the U.S., PF614-MPAR.

Key Points: 
  • This award will provide $2.8 million to initiate a Phase 1 study of the first MPARoverdose protection product in the U.S., PF614-MPAR.
  • Importantly, our next-generation opioid platform is highly differentiated from currently marketed opioid products and designed to significantly reduce abuse potential and overdose protection.
  • PF614-MPAR is designed as an extended-release oxycodone prodrug with both trypsin-activated abuse protection (TAAP) and overdose protection through multi-pill abuse resistance (MPAR) technology.
  • Ensysce Biosciences, San Diego, CA is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs.

Worldwide Pulmonary Drugs Industry to 2026 - Rising Prevalence of Pulmonary Diseases is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021
Pharmaceutical, Health, Cardiology, Human behavior, Habits, Articles, Life sciences, Biotechnology, Drug culture, Smoking, Tobacco smoking, Biosimilar, Tobacco

The Global Pulmonary Drugs Market is estimated to be USD 56.9 Bn in 2021 and is expected to reach USD 67.6 Bn by 2026, growing at a CAGR of 3.5%.

Key Points: 
  • The Global Pulmonary Drugs Market is estimated to be USD 56.9 Bn in 2021 and is expected to reach USD 67.6 Bn by 2026, growing at a CAGR of 3.5%.
  • The factors that are driving the market include the rising prevalence of pulmonary diseases and the growing geriatric population.
  • With the entry of innovative drugs into the markets, there is an increased scope for market growth.
  • Government and non-government initiatives, and the availability of biosimilars, increasing tobacco smoking are fuelling the market growth.

Greenspoon Marder Expands Cannabis Law Practice In The Midwest And Names New Cannabis Group Chair

Retrieved on: 
Tuesday, July 6, 2021
Entheogens, Cannabis and religion, Cannabis culture, Drug culture, Cannabis, Psychoactive drugs, Rachel K. Gillette

Additionally, the firm is pleased to name partner Nick Richards as Chair of the Cannabis Law practice group.

Key Points: 
  • Additionally, the firm is pleased to name partner Nick Richards as Chair of the Cannabis Law practice group.
  • "We are thrilled to bolster our leading cannabis practice by welcoming this team of highly regarded cannabis attorneys.
  • With a $1B+ market in the legal cannabis industry, Illinois has been a key focus in our strategic plan of expansion in the Midwest," says Gerry Greenspoon , co-managing director at Greenspoon Marder.
  • His dedication to the firm, extensive knowledge of the cannabis legal landscape and broad list of industry contacts make him a great fit for this new role as chair of the Cannabis Law practice group," says Michael Marder , co-managing director at Greenspoon Marder.

Unity Rd. Opens First U.S. Dispensary Franchise in Boulder, Colo.

Retrieved on: 
Tuesday, June 29, 2021
Cannabis culture, Cannabis shop, Drug culture, Dispensary

, the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), is opening its first franchise shop this week in Boulder, Colorado.

Key Points: 
  • , the cannabis dispensary franchise from Item 9 Labs Corp. (OTCQX: INLB), is opening its first franchise shop this week in Boulder, Colorado.
  • a cannabis dispensary franchise with the mission of keeping dispensary ownership, and the wealth that comes along with it, local.
  • The cannabis dispensary franchise plans to convert the stores into Unity Rd.
  • 's Director of Franchise Operations, Jennifer Zarezadeh, has relocated to Denver to support the Wetzels and oversee future Unity Rd.